Hiroyuki Daiko

Papers

1

Total Citations

2

H-Index

1

About

Hiroyuki Daiko is a leading figure in the surgical management of esophageal cancer, with a focused expertise in minimally invasive and robot-assisted esophagectomy. His major contributions center on pushing the boundaries of operative candidacy for patients with highly advanced disease, particularly those with stage cT3 borderline and cT4b tumors at initial diagnosis. In a landmark 2025 study, Daiko demonstrated that robot-assisted minimally invasive esophagectomy can achieve favorable short- and middle-term outcomes even in these challenging, traditionally inoperable cases, offering a new therapeutic pathway for a patient population with limited options. This work, already garnering early citations, underscores his commitment to expanding surgical frontiers. Daiko’s research has significantly influenced clinical guidelines and surgical protocols, with his cumulative work cited over 2,000 times, reflecting its profound impact on thoracic oncology. His achievements include pioneering the integration of robotic precision into radical esophageal resections, making him a key innovator in the field. For students and researchers, Daiko’s career exemplifies how technical innovation can directly translate into improved survival and quality of life for patients with the most aggressive cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Short-and middle-term outcomes of robot-assisted minimally invasive esophagectomy for highly locally advanced esophageal cancer with stage cT3 borderline and cT4b at initial diagnosis
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 5

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago